Humana Inc. (NYSE:HUM) Shares Sold by Applied Finance Capital Management LLC

Applied Finance Capital Management LLC trimmed its holdings in shares of Humana Inc. (NYSE:HUM - Free Report) by 74.2% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 2,895 shares of the insurance provider's stock after selling 8,337 shares during the period. Applied Finance Capital Management LLC's holdings in Humana were worth $734,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors also recently bought and sold shares of the company. FPC Investment Advisory Inc. acquired a new stake in shares of Humana in the 4th quarter worth approximately $27,000. Centricity Wealth Management LLC acquired a new stake in Humana in the fourth quarter valued at $30,000. LFA Lugano Financial Advisors SA grew its holdings in Humana by 56.3% in the fourth quarter. LFA Lugano Financial Advisors SA now owns 125 shares of the insurance provider's stock valued at $32,000 after purchasing an additional 45 shares during the last quarter. OFI Invest Asset Management purchased a new position in shares of Humana in the fourth quarter valued at $33,000. Finally, Atwood & Palmer Inc. raised its stake in shares of Humana by 64.5% during the 4th quarter. Atwood & Palmer Inc. now owns 153 shares of the insurance provider's stock worth $39,000 after buying an additional 60 shares during the last quarter. Institutional investors and hedge funds own 92.38% of the company's stock.

Analysts Set New Price Targets

Several equities analysts have weighed in on HUM shares. Barclays raised their target price on shares of Humana from $270.00 to $322.00 and gave the company an "equal weight" rating in a report on Friday. Cantor Fitzgerald restated a "neutral" rating and set a $290.00 price objective on shares of Humana in a research report on Wednesday, February 12th. Morgan Stanley lowered their target price on Humana from $301.00 to $285.00 and set an "equal weight" rating on the stock in a report on Wednesday, February 12th. Guggenheim began coverage on shares of Humana in a report on Wednesday, April 9th. They set a "buy" rating and a $326.00 price target for the company. Finally, Truist Financial increased their target price on Humana from $290.00 to $325.00 and gave the stock a "hold" rating in a research report on Friday. Seventeen equities research analysts have rated the stock with a hold rating and seven have assigned a buy rating to the stock. Based on data from MarketBeat, the stock currently has a consensus rating of "Hold" and an average target price of $288.60.

Remove Ads

Humana Stock Down 3.4 %

NYSE:HUM traded down $10.07 on Monday, reaching $284.97. The stock had a trading volume of 460,776 shares, compared to its average volume of 1,639,872. The company has a 50-day moving average of $265.55 and a 200 day moving average of $270.35. The company has a current ratio of 1.76, a quick ratio of 1.76 and a debt-to-equity ratio of 0.68. The stock has a market cap of $34.39 billion, a P/E ratio of 28.64, a price-to-earnings-growth ratio of 2.05 and a beta of 0.62. Humana Inc. has a 12-month low of $213.31 and a 12-month high of $406.46.

Humana (NYSE:HUM - Get Free Report) last issued its quarterly earnings results on Tuesday, February 11th. The insurance provider reported ($2.16) EPS for the quarter, beating analysts' consensus estimates of ($2.26) by $0.10. Humana had a return on equity of 11.70% and a net margin of 1.02%. On average, research analysts predict that Humana Inc. will post 16.47 earnings per share for the current year.

Humana Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Friday, April 25th. Stockholders of record on Friday, March 28th will be issued a $0.885 dividend. The ex-dividend date is Friday, March 28th. This represents a $3.54 dividend on an annualized basis and a dividend yield of 1.24%. Humana's dividend payout ratio (DPR) is 35.58%.

Humana Company Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.